Clinical Trial News and Research

RSS

FDA approves new treatment for people with hairy cell leukemia

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

Twice-a-year MRI more effective than mammograms for women with genetic breast cancer risk

Getting magnetic resonance imaging scans twice a year instead of one annual mammogram is far more effective at detecting early breast cancers in young women with a high-risk genetic profile than mammograms alone, according to a research team based at the University of Chicago Medicine and the University of Washington, Seattle.

14 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Novel treatment for hairy cell leukemia approved by FDA

The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

Johns Hopkins scientists successfully perform 3D personalized virtual simulations of the heart

In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3D personalized virtual simulations of the heart to accurately identify where cardiac specialists should electrically destroy cardiac tissue to stop potentially fatal irregular and rapid heartbeats in patients with scarring in the heart.

12 Sep 2018

FDA awards grants to enhance development of medical devices for pediatric patients

The U.S. Food and Drug Administration announced today that it has awarded five grants totaling up to $6 million per year over the next five years to Pediatric Device Consortia across the country that will provide advice and support services to innovators of children's medical devices.

12 Sep 2018

PAREXEL launches Patient Innovation Center to improve drug development process

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center.

From Parexel 12 Sep 2018

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Novartis, a leader in immuno-dermatology, announced today new data from a patient preference survey showing psoriasis patients want their treatment to go beyond just clear skin and safety.

12 Sep 2018

Clinical trial begins to find better treatment for chronic cases of PKDL in Africa

A clinical trial to find a better treatment for severe or chronic cases of post kala-azar dermal leishmaniasis (PKDL) in Africa has begun in Dooka, Sudan.

12 Sep 2018

Consuming more caffeine may help reduce risk of death for people with kidney disease

A new study in Nephrology Dialysis Transplantation indicates that consuming more caffeine may help reduce the risk of death for people with chronic kidney disease.

12 Sep 2018

Using stem cells extracted from baby teeth to regrow dental tissues

Sometimes kids trip and fall, and their teeth take the hit. Nearly half of children suffer some injury to a tooth during childhood. When that trauma affects an immature permanent tooth, it can hinder blood supply and root development, resulting in what is essentially a "dead" tooth.

12 Sep 2018

Wake Forest Baptist receives federal grants to develop new treatments for neurological diseases

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, has awarded Wake Forest Baptist Medical Center two five-year grants, each worth approximately $1.5 million, to participate in two nationwide clinical trial networks.

12 Sep 2018

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health.

11 Sep 2018

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Platelet inhibition with aspirin is the cornerstone of medical therapy for coronary artery disease. In the era of percutaneous coronary intervention with drug-eluting stents, dual anti-platelet therapy with the addition of clopidogrel became the mainstay of therapy.

11 Sep 2018

Barrow Institute initiates $50 million effort to seek cure for glioblastoma

Barrow Neurological Institute has initiated a $50 million effort, supported by the single largest research grant in the history of brain tumor research, to seek a cure for the deadliest form of brain cancer.

11 Sep 2018

New malaria drug starts clinical trials

After decades a new drug against malaria has been developed and first clinical trials of this new investigational drug is soon to begin. Enrolment for the same has already started. This study is to be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH). It is to take place at the Duke University School of Medicine in Durham, North Carolina.

11 Sep 2018

Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment

With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity.

10 Sep 2018

Metabolic dysfunction drives chronic illness

Much of modern Western medicine is based upon the treatment of acute, immediate harm, from physical injury to infections, from broken bones and the common cold to heart and asthma attacks.

7 Sep 2018

EC approves update of INVOKANA and VOKANAMET labeling to include changes to indication statement

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted approval to update the INVOKANA® and VOKANAMET® labeling to include changes to the indication statement for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

7 Sep 2018

Transcranial direct current stimulation may help aphasia patients recover use of language

Neuroscientists at the University of South Carolina and the Medical University of South Carolina have collaborated on a study in the field of aphasia that has successfully paved the way for a large clinical trial.

7 Sep 2018

Clinical Trial News and Research

FDA approves new treatment for people with hairy cell leukemia

Twice-a-year MRI more effective than mammograms for women with genetic breast cancer risk

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Novel treatment for hairy cell leukemia approved by FDA

Johns Hopkins scientists successfully perform 3D personalized virtual simulations of the heart

FDA awards grants to enhance development of medical devices for pediatric patients

PAREXEL launches Patient Innovation Center to improve drug development process

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Clinical trial begins to find better treatment for chronic cases of PKDL in Africa

Consuming more caffeine may help reduce risk of death for people with kidney disease

Using stem cells extracted from baby teeth to regrow dental tissues

Wake Forest Baptist receives federal grants to develop new treatments for neurological diseases

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

Study aims to understand role of clopidogrel in patients with cardiovascular disease

Barrow Institute initiates $50 million effort to seek cure for glioblastoma

New malaria drug starts clinical trials

Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment

Metabolic dysfunction drives chronic illness

EC approves update of INVOKANA and VOKANAMET labeling to include changes to indication statement

Transcranial direct current stimulation may help aphasia patients recover use of language

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer